Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark M Hassall

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
BMJ Case Reports|April 21, 2016
Single-eye trial of a topical carbonic anhydrase inhibitor versus intravitreal bevacizumab for the treatment of taxane drug-induced cystoid macula oedemaMark M Hassall, Nicholas Howard Andrew
Clinical & Experimental Ophthalmology|June 2, 2018
Canaloplasty case series for primary open-angle glaucoma in rural AustraliaDeric W De Wit, Mark M Hassall
Asia-Pacific Journal of Ophthalmology (Philadelphia, Pa.)|January 29, 2021
Ruptured Retinal Arterial MacroaneurysmLiana Dedina, Mark M Hassall, Paula Anderson
The Yale Journal of Biology and Medicine|December 21, 2017
Gene Therapy for Color BlindnessMark M Hassall, Alun R Barnard, Robert E MacLaren
Neuro-Ophthalmology (Aeolus Press)|March 11, 2022
Pallid Disc Oedema in a Young Patient: Clinical and Diagnostic ChallengeLiana Dedina, Mark M Hassall, Shilpanjali Jesudason, et al.
Ophthalmology|May 14, 2026
Intravitreal Bevacizumab Improves Trabeculectomy Survival at 3 Years: Long-term Follow-up from The 'Bevacizumab in Trabeculectomy Study'John Landers, Sean Mullany, Mark M Hassall, et al.
Annual Review of Genomics and Human Genetics|April 10, 2024
Polygenic Risk Scores Driving Clinical Change in GlaucomaAntonia Kolovos, Mark M Hassall, Owen M Siggs, et al.
BMC Medical Genomics|January 30, 2025
Development and evaluation of patient-centred polygenic risk score reports for glaucoma screeningGeorgina L Hollitt, Mark M Hassall, Owen M Siggs, et al.
Ophthalmology|June 13, 2025
REPLYAntonia Kolovos, Ayub Qassim, Mark M Hassall, et al.
Translational Vision Science & Technology|June 10, 2021
Risk Stratification and Clinical Utility of Polygenic Risk Scores in OphthalmologyAyub Qassim, Emmanuelle Souzeau, Georgie Hollitt, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
BMJ Case Reports|April 21, 2016
Single-eye trial of a topical carbonic anhydrase inhibitor versus intravitreal bevacizumab for the treatment of taxane drug-induced cystoid macula oedemaMark M Hassall, Nicholas Howard Andrew
Clinical & Experimental Ophthalmology|June 2, 2018
Canaloplasty case series for primary open-angle glaucoma in rural AustraliaDeric W De Wit, Mark M Hassall
Asia-Pacific Journal of Ophthalmology (Philadelphia, Pa.)|January 29, 2021
Ruptured Retinal Arterial MacroaneurysmLiana Dedina, Mark M Hassall, Paula Anderson
The Yale Journal of Biology and Medicine|December 21, 2017
Gene Therapy for Color BlindnessMark M Hassall, Alun R Barnard, Robert E MacLaren
Neuro-Ophthalmology (Aeolus Press)|March 11, 2022
Pallid Disc Oedema in a Young Patient: Clinical and Diagnostic ChallengeLiana Dedina, Mark M Hassall, Shilpanjali Jesudason, et al.
Ophthalmology|May 14, 2026
Intravitreal Bevacizumab Improves Trabeculectomy Survival at 3 Years: Long-term Follow-up from The 'Bevacizumab in Trabeculectomy Study'John Landers, Sean Mullany, Mark M Hassall, et al.
Annual Review of Genomics and Human Genetics|April 10, 2024
Polygenic Risk Scores Driving Clinical Change in GlaucomaAntonia Kolovos, Mark M Hassall, Owen M Siggs, et al.
BMC Medical Genomics|January 30, 2025
Development and evaluation of patient-centred polygenic risk score reports for glaucoma screeningGeorgina L Hollitt, Mark M Hassall, Owen M Siggs, et al.
Ophthalmology|June 13, 2025
REPLYAntonia Kolovos, Ayub Qassim, Mark M Hassall, et al.
Translational Vision Science & Technology|June 10, 2021
Risk Stratification and Clinical Utility of Polygenic Risk Scores in OphthalmologyAyub Qassim, Emmanuelle Souzeau, Georgie Hollitt, et al.
Pageof 3